# Commission Implementing Regulation (EU) 2019/336 of 27 February 2019 amending Regulation (EU) No 1141/2010 and Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of 1-methylcyclopropene, famoxadone, mancozeb, methiocarb, methoxyfenozide, pirimicarb, pirimiphos-methyl and thiacloprid (Text with EEA relevance), Signature

Extent: E+W+S+N.I.

This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 27 February 2019.
For the Commission
The President
Jean-Claude Juncker

---
Source: https://www.legislation.gov.uk/eur/2019/336/signature (the official version)
Page: https://openlegislation.uk/eu-regulation-2019-336/signature
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.